{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:15:42Z","timestamp":1758039342120,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ad.2022.03.039","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T11:47:45Z","timestamp":1690372065000},"page":"T831-T832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Ulerythema Ophryogenes Induced by Dabrafenib"],"prefix":"10.1016","volume":"114","author":[{"given":"A.","family":"Aramburu Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Udondo Gonz\u00e1lez del T\u00e1nago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Orbea Sope\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Gonz\u00e1lez Hermosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2022.03.039_bib0055","first-page":"83","article-title":"Ulerythema ophryogenes: updates and insights","volume":"93","author":"Morton","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2022.03.039_bib0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1684\/ejd.2018.3385","article-title":"Ulerythema ophryogenes and keratosis pilaris","volume":"28","author":"Coelho de Sousa","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2022.03.039_bib0065","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/DSS.0000000000002441","article-title":"Light and laser treatments for keratosis pilaris: a systematic review","volume":"46","author":"Kechichian","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2022.03.039_bib0070","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00381-021-05138-3","article-title":"Targeted therapy for pediatric low-grade glioma","volume":"37","author":"P\u00e9rez","year":"2021","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ad.2022.03.039_bib0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ad.2018.10.019","article-title":"Adverse hair reactions to new targeted therapies for cancer","volume":"110","author":"Mir-Bonaf\u00e9","year":"2019","journal-title":"Actas Dermosifilogr"},{"key":"10.1016\/j.ad.2022.03.039_bib0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.annder.2013.02.031","article-title":"Effets ind\u00e9sirables cutan\u00e9s des inhibiteurs de BRAF: revue syst\u00e9matique","volume":"140","author":"Sibaud","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2022.03.039_bib0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jdv.16894","article-title":"Systematic review of BRAF\/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs)","volume":"35","author":"Torres-Navarro","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2022.03.039_bib0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/ejhpharm-2020-002347","article-title":"The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis","volume":"28","author":"Peng","year":"2021","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.ad.2022.03.039_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D3228032159","article-title":"Nilontinib induced keratosis pilaris atrophicans","volume":"22","author":"Khetarpal","year":"2016","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2022.03.039_bib0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ad.2016.05.019","article-title":"Cutaneous adverse events of new anti-melanoma therapies: classification and management","volume":"108","author":"Hwang","year":"2017","journal-title":"Actas Dermosifiliogr"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023006208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023006208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:16:39Z","timestamp":1757553399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023006208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0001731023006208"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.039","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Ulerythema Ophryogenes Induced by Dabrafenib","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}